DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Smith I et al.
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.

Lancet 2007;
369: 29-36

Download Bibliographical Data

Search in:
Access:
Access: